These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 2547387

  • 1. Antihypertensive mechanism of alacepril. Effects of its metabolites on the peripheral sympathetic nervous system.
    Minato H, Hosoki K, Hayashi K, Sawayama T, Kadokawa T, Hashimoto M.
    Arzneimittelforschung; 1989 Mar; 39(3):319-24. PubMed ID: 2547387
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive mechanism of alacepril: effect on norepinephrine-induced vasoconstrictive response in vitro and in vivo.
    Takeyama K, Minato H, Ikeno A, Hosoki K, Kadokawa T.
    Arzneimittelforschung; 1986 Mar; 36(1):74-7. PubMed ID: 3513780
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs.
    Takeyama K, Minato H, Fukuya F, Kawahara S, Hosoki K, Kadokawa T.
    Arzneimittelforschung; 1985 Mar; 35(10):1507-12. PubMed ID: 3000390
    [Abstract] [Full Text] [Related]

  • 4. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
    Matsuno Y, Taira N, Fujitani B, Ito T, Kadokawa T.
    Arzneimittelforschung; 1986 Mar; 36(1):55-62. PubMed ID: 3513777
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 2nd communication: Effects on central nervous and sensory systems and on the other functions.
    Matsuno Y, Hori H, Oka M, Nakamura H, Ito T, Kadokawa T.
    Arzneimittelforschung; 1986 Mar; 36(1):62-8. PubMed ID: 3513778
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of antihypertensive treatment with alacepril on insulin resistance in diabetic spontaneously hypertensive rats.
    Sato T, Nara Y, Kato Y, Yamori Y.
    Metabolism; 1996 Apr; 45(4):457-62. PubMed ID: 8609831
    [Abstract] [Full Text] [Related]

  • 11. Effect of central administration of MK-422 (the diacid form of enalapril) on the development of hypertension in the spontaneously hypertensive rat.
    Berecek KH, Nagahama S, Oparil S.
    J Hypertens Suppl; 1984 Dec; 2(3):S63-6. PubMed ID: 6100756
    [Abstract] [Full Text] [Related]

  • 12. Disposition and metabolism of the novel antihypertensive agent alacepril in rats.
    Matsumoto K, Miyazaki H, Fujii T, Yoshida K, Amejima H, Hashimoto M.
    Arzneimittelforschung; 1986 Dec; 36(1):40-6. PubMed ID: 3513776
    [Abstract] [Full Text] [Related]

  • 13. Pre- and postjunctional inhibition of vascular sympathetic function by captopril in SHR. Implication of vascular angiotensin II in hypertension and antihypertensive actions of captopril.
    Antonaccio MJ, Kerwin L.
    Hypertension; 1981 Dec; 3(3 Pt 2):I54-62. PubMed ID: 6167515
    [Abstract] [Full Text] [Related]

  • 14. Enhanced in vivo responsiveness of presynaptic angiotensin II receptor-mediated facilitation of vascular adrenergic neurotransmission in spontaneously hypertensive rats.
    Cline WH.
    J Pharmacol Exp Ther; 1985 Mar; 232(3):661-9. PubMed ID: 2983066
    [Abstract] [Full Text] [Related]

  • 15. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK, Dubinion JH, Mi Z.
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [Abstract] [Full Text] [Related]

  • 16. Effects of long-term treatment with angiotensin-converting enzyme inhibitor on angiotensin II and prostacyclin release from mesenteric arteries in spontaneously hypertensive rats.
    Ito M, Soma M, Izumi Y, Kanmatsuse K.
    Prostaglandins Leukot Essent Fatty Acids; 1995 Nov; 53(5):359-63. PubMed ID: 8596776
    [Abstract] [Full Text] [Related]

  • 17. Metabolism of protein conjugate of desacetyl-alacepril and its effect on angiotensin converting enzyme in renal hypertensive rats.
    Matsumoto K, Nambu K, Fujii T, Takeyama K, Miyazaki H, Hashimoto M.
    Arzneimittelforschung; 1986 Nov; 36(1):52-4. PubMed ID: 3006711
    [Abstract] [Full Text] [Related]

  • 18. Free radical scavenging properties of alacepril metabolites and lisinopril.
    Noda Y, Mori A, Packer L.
    Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):125-36. PubMed ID: 9226747
    [Abstract] [Full Text] [Related]

  • 19. Participation of angiotensin II in pressor response and norepinephrine release to spinal nerve stimulation in pithed rats.
    Mizunuma Y, Suzuki-Kusaba M, Hisa H, Yoshida M, Satoh S.
    Biol Pharm Bull; 2000 Dec; 23(12):1455-7. PubMed ID: 11145177
    [Abstract] [Full Text] [Related]

  • 20. Sympathetic function in spontaneously hypertensive rats after chronic administration of captopril.
    Berecek KH, Kirk KA, Nagahama S, Oparil S.
    Am J Physiol; 1987 Apr; 252(4 Pt 2):H796-806. PubMed ID: 3551634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.